SkillAgentSearch skills...

armored-cart-design-agent

The Armored CAR-T Design Agent provides AI-assisted design of next-generation armored CAR-T cells engineered to express cytokines, chemokines, or other enhancing factors.

Install / Use

npx skills add FreedomIntelligence/OpenClaw-Medical-Skills --skill armored-cart-design-agent

Installs into whichever agent you are using.

About this skill
📄

SKILL.md

Installable skill definition

Quality Score

85/100

Supported Platforms

Zed

Our assessment of armored-cart-design-agent

armored-cart-design-agent scores 85/100 on our quality scale, 36th of 47 Healthcare & Life Sciences skills we index.

Its SKILL.md is 7.7 KB long, well organised into 27 sections with 1 code example: a thorough specification that gives an agent plenty to work with.

With 3,034 GitHub stars, it is one of the more widely adopted skills in the catalogue.

Substance
29/30
Structure
17/20
Description
15/15
Adoption
15/20
Freshness
11/15

Maintenance, license and trust

  • The repository was last updated about 4 months ago. That is recent enough to be usable, but agent tooling moves fast, so check the instructions against your agent's current version.
  • Our last check on 2026-11-04 found the source still online.
  • No license is declared. By default that means all rights are reserved: you can read it, but reusing or redistributing it is not clearly permitted. Ask the author before building on it commercially.
  • Its trust signals score 86/100, with 1 caution from licensing, adoption, age or documentation. These come from repository metadata, not a code audit — read the skill file before letting an agent act on it.

Safety scan

No issues found

Our scan of the whole file found no instruction hijacking, hidden characters, credential access, data exfiltration or destructive commands. An AI review of the same text found nothing harmful.

AI review by kimi-k2.7-code on 2026-09-30. Automated pattern scan on 2026-09-29. It catches known dangerous patterns, not every risk — read a skill before letting an agent act on it.

armored-cart-design-agent compared with similar skills

All 4 of these similar skills score higher than armored-cart-design-agent; compare them before choosing.

SkillScoreStarsUpdatedFormat
armored-cart-design-agent (this skill)by FreedomIntelligence853.0k4mo agoSKILL.md
taste-skillby Leonxlnx100116.8k8d agoCLAUDE.md
Claude-Code-Game-Studiosby Donchitos10039.7k7d agoCLAUDE.md
x402by browser-use100121.0k3d agoSKILL.md
algorithmic-artby anthropics100177.9k55d agoSKILL.md

Frequently asked questions

How do I install armored-cart-design-agent?
Run npx skills add FreedomIntelligence/OpenClaw-Medical-Skills --skill armored-cart-design-agent. The install tabs above show the steps for each supported agent.
Which AI agents does armored-cart-design-agent work with?
It is written for Zed, as a SKILL.md file. Other agents that read the same format can often use it too.
Is armored-cart-design-agent safe to use?
Our scan of the whole file found no instruction hijacking, hidden characters, credential access, data exfiltration or destructive commands. An AI review of the same text found nothing harmful. It declares no license and scores 86/100 on trust signals. Skills are instructions an agent will follow, so read the file before installing it and do not approve commands you do not understand.
Is armored-cart-design-agent still maintained?
The repository was last updated about 4 months ago. That is recent enough to be usable, but agent tooling moves fast, so check the instructions against your agent's current version.
<!-- # COPYRIGHT NOTICE # This file is part of the "Universal Biomedical Skills" project. # Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu> # All Rights Reserved. # # This code is proprietary and confidential. # Unauthorized copying of this file, via any medium is strictly prohibited. # # Provenance: Authenticated by MD BABU MIA -->

name: 'armored-cart-design-agent' description: 'AI-powered design of armored CAR-T cells with cytokine/chemokine expression for enhanced solid tumor efficacy, including IL-12, IL-15, IL-18, and IL-7 armoring strategies.' measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes. allowed-tools:

  • read_file
  • run_shell_command

Armored CAR-T Design Agent

The Armored CAR-T Design Agent provides AI-assisted design of next-generation armored CAR-T cells engineered to express cytokines, chemokines, or other enhancing factors. These armored T cells overcome solid tumor challenges including immunosuppressive TME, poor trafficking, and T cell exhaustion, with recent clinical success in lymphoma (IL-18) and ongoing trials with IL-12, IL-15, and IL-7.

When to Use This Skill

  • When designing CAR-T cells for solid tumor applications.
  • For selecting optimal armoring payloads (cytokines, chemokines).
  • To optimize cytokine expression levels and regulation.
  • When engineering safety switches for armored constructs.
  • For predicting armored CAR-T efficacy and safety profiles.

Core Capabilities

  1. Armoring Payload Selection: Choose optimal cytokines for tumor type.

  2. Expression Level Optimization: Balance efficacy vs toxicity.

  3. Inducible System Design: Engineer regulated expression systems.

  4. Safety Switch Integration: Design kill switches and controls.

  5. Construct Optimization: Optimize transgene configuration.

  6. Efficacy Prediction: Predict enhanced tumor killing.

Armoring Strategies

| Cytokine | Mechanism | Clinical Status | Tumor Types | |----------|-----------|-----------------|-------------| | IL-12 | Th1 polarization, IFN-gamma | Phase I/II | Solid tumors | | IL-15 | T/NK persistence | Phase I/II | Hematologic, solid | | IL-18 | Inflammasome, IFN-gamma | Phase I (promising) | Lymphoma | | IL-7 | T cell survival | Phase I | Multiple | | IL-21 | T cell proliferation | Preclinical | Multiple | | CCL19/21 | T cell trafficking | Preclinical | Solid tumors |

Construct Architecture Options

| Component | Options | Consideration | |-----------|---------|---------------| | Promoter | EF1a, PGK, CAG, NFAT-inducible | Expression level/timing | | Signal Peptide | Native, IL-2ss, IgK | Secretion efficiency | | Cytokine | Membrane-bound vs secreted | Local vs systemic | | Linker | T2A, P2A, IRES | Co-expression efficiency | | Kill Switch | iCasp9, HSV-TK, CD20 | Safety control | | Position | Before/after CAR | Expression balance |

Workflow

  1. Input: Target tumor type, TME characteristics, CAR design.

  2. Payload Selection: Rank armoring strategies for tumor context.

  3. Expression Design: Optimize promoter, levels, regulation.

  4. Safety Engineering: Add appropriate control switches.

  5. Construct Assembly: Generate optimized DNA sequence.

  6. Efficacy Prediction: Model enhanced killing and persistence.

  7. Output: Optimized armored CAR construct with annotations.

Example Usage

User: "Design an armored CAR-T for pancreatic cancer targeting mesothelin with IL-12 armoring for TME remodeling."

Agent Action:

python3 Skills/Immunology_Vaccines/Armored_CART_Design_Agent/design_armored_cart.py \
    --car_target mesothelin \
    --tumor_type pancreatic \
    --armoring_payload IL-12 \
    --expression_system NFAT_inducible \
    --safety_switch iCasp9 \
    --backbone lentiviral \
    --optimize_codon human \
    --output armored_cart_design/

Output Components

| Output | Description | Format | |--------|-------------|--------| | Construct Sequence | Full transgene DNA | .fasta, .gb | | Construct Map | Annotated visualization | .png, .pdf | | Expression Model | Predicted levels | .json | | Safety Analysis | Risk assessment | .json | | Manufacturing Guide | Production recommendations | .md | | Predicted Efficacy | Tumor killing model | .json |

IL-12 Armoring Details

| Aspect | Design Choice | Rationale | |--------|---------------|-----------| | Configuration | Tethered IL-12 (p70) | Localized, reduced toxicity | | Expression | NFAT-inducible | Activation-dependent | | Dose | Low-level expression | Safety optimization | | Combination | With PD-1 knockout | Enhanced activity |

IL-18 Armoring Details

| Aspect | Design Choice | Rationale | |--------|---------------|-----------| | Configuration | Secreted mature IL-18 | Enhanced IFN-gamma | | Expression | Constitutive or inducible | Context-dependent | | Clinical Results | Lymphoma responses | Validated approach | | Combination | With IL-21 | Synergistic |

IL-15 Armoring Details

| Aspect | Design Choice | Rationale | |--------|---------------|-----------| | Configuration | Membrane-tethered IL-15/IL-15Ra | Cis-presentation | | Expression | Constitutive moderate | Persistence without toxicity | | Benefit | Reduced IL-2 dependence | Manufacturing advantage | | Safety | Lower CRS risk | Clinical benefit |

AI/ML Components

Payload Selection:

  • TME profiling to match cytokine needs
  • Multi-objective optimization
  • Clinical outcome modeling

Expression Optimization:

  • Promoter strength prediction
  • Codon optimization
  • mRNA stability modeling

Safety Prediction:

  • CRS/ICANS risk modeling
  • Off-tumor activity prediction
  • Systemic cytokine levels

Safety Considerations

| Risk | Mitigation | Implementation | |------|------------|----------------| | Cytokine storm | Inducible expression | NFAT promoter | | Systemic toxicity | Membrane tethering | Localized effect | | Uncontrolled proliferation | Kill switch | iCasp9 | | On-target off-tumor | Regulatable CAR | Logic gates |

Clinical Trials (2025-2026)

| Trial | Armoring | Target | Cancer | Status | |-------|----------|--------|--------|--------| | NCT03721068 | IL-18 | CD19 | Lymphoma | Phase I (positive) | | NCT04119024 | IL-12 | GD2 | Neuroblastoma | Phase I | | NCT03932565 | IL-15/21 | CD19 | B-ALL | Phase I | | Multiple | IL-7/CCL19 | Various | Solid | Preclinical |

Prerequisites

  • Python 3.10+
  • Biopython for sequence handling
  • CAR design databases
  • Codon optimization tools
  • Structure prediction (optional)

Related Skills

  • CART_Design_Optimizer_Agent - Base CAR optimization
  • NK_Cell_Therapy_Agent - NK cell engineering
  • Cytokine_Storm_Analysis_Agent - Safety analysis
  • TCell_Exhaustion_Analysis_Agent - Exhaustion prevention

Manufacturing Considerations

| Aspect | Armored CAR Challenge | Solution | |--------|----------------------|----------| | Vector Size | Larger transgene | Optimize construct | | Transduction | Lower efficiency | Increase MOI | | Expansion | Cytokine effects | Tune expression | | Characterization | Complex phenotype | Enhanced QC |

Special Considerations

  1. Tumor Type Matching: Different tumors need different armoring
  2. Expression Timing: Constitutive vs inducible tradeoffs
  3. Dose Finding: Balance efficacy vs toxicity
  4. Combination: Consider with checkpoint knockout
  5. Manufacturing: Larger constructs affect production

Efficacy Enhancement Mechanisms

| Mechanism | Cytokine | Effect | |-----------|----------|--------| | Persistence | IL-15, IL-7 | Longer survival | | TME Remodeling | IL-12 | M2→M1, DC activation | | Bystander Killing | IL-18 | Enhanced IFN-gamma | | Trafficking | CCL19/21 | T cell recruitment | | Anti-exhaustion | IL-21 | Stem-like maintenance |

Author

AI Group - Biomedical AI Platform

<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->

Related Skills

View on GitHub
GitHub Stars3.0k
CategoryHealthcare
Updated3mo ago
Forks413

Languages

Python

Trust signals

86/100

From repository metadata: license, adoption, age and documentation. Not a code audit — see the Safety scan above for what the skill file itself contains.

1 medium1 info